MXPA03005338A - Etapa de ciclizacion en el procedimiento de elaboracion de quinolonas y naftiridinas. - Google Patents

Etapa de ciclizacion en el procedimiento de elaboracion de quinolonas y naftiridinas.

Info

Publication number
MXPA03005338A
MXPA03005338A MXPA03005338A MXPA03005338A MXPA03005338A MX PA03005338 A MXPA03005338 A MX PA03005338A MX PA03005338 A MXPA03005338 A MX PA03005338A MX PA03005338 A MXPA03005338 A MX PA03005338A MX PA03005338 A MXPA03005338 A MX PA03005338A
Authority
MX
Mexico
Prior art keywords
making
naphthyridines
quinolones
process step
cyclization process
Prior art date
Application number
MXPA03005338A
Other languages
English (en)
Inventor
Reddy Mundla Sreenivasa
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MXPA03005338A publication Critical patent/MXPA03005338A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
MXPA03005338A 2000-12-14 2001-12-07 Etapa de ciclizacion en el procedimiento de elaboracion de quinolonas y naftiridinas. MXPA03005338A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25563300P 2000-12-14 2000-12-14
PCT/US2001/048536 WO2002048113A1 (en) 2000-12-14 2001-12-07 Cyclization process step in the making of quinolones and naphthyridines

Publications (1)

Publication Number Publication Date
MXPA03005338A true MXPA03005338A (es) 2003-10-06

Family

ID=22969207

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03005338A MXPA03005338A (es) 2000-12-14 2001-12-07 Etapa de ciclizacion en el procedimiento de elaboracion de quinolonas y naftiridinas.

Country Status (19)

Country Link
EP (1) EP1343766B1 (es)
JP (2) JP4417007B2 (es)
KR (1) KR100603163B1 (es)
CN (1) CN1232508C (es)
AT (1) ATE300522T1 (es)
AU (2) AU2905702A (es)
BR (1) BR0116229A (es)
CA (1) CA2427831C (es)
CZ (1) CZ20031379A3 (es)
DE (1) DE60112325T2 (es)
DK (1) DK1343766T3 (es)
ES (1) ES2247190T3 (es)
HU (1) HUP0303991A3 (es)
IL (2) IL155677A0 (es)
MX (1) MXPA03005338A (es)
NO (1) NO325236B1 (es)
NZ (1) NZ525569A (es)
PL (1) PL207394B1 (es)
WO (1) WO2002048113A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6803469B2 (en) * 2002-08-05 2004-10-12 The Procter & Gamble Company Process for preparing quinolone antibiotic intermediates
KR100735587B1 (ko) * 2002-08-05 2007-07-04 더 프록터 앤드 갬블 캄파니 퀴놀론계 항생제 중간체의 제조 방법
CZ2004764A3 (cs) 2002-11-20 2005-02-16 Japan Tobacco Inc 4-Oxochinolinová sloučenina a její použití jako inhibitoru HIV-integrázy
US7402674B2 (en) 2004-01-31 2008-07-22 Sanofi-Aventis Deutschland Gmbh, 7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
CN101437801B (zh) 2006-03-06 2013-02-06 日本烟草产业株式会社 制备4-氧代喹啉化合物的方法
IN2014CN00613A (es) 2006-03-06 2015-08-21 Japan Tobacco Inc
BRPI0716752A2 (pt) 2006-09-12 2013-09-17 Gilead Sciences Inc processo e intermediÁrios para preparo de inibidores de intergrase
US8658183B2 (en) 2007-08-09 2014-02-25 Taigen Biotechnology Company, Ltd. Antimicrobial parenteral formulation
AR068403A1 (es) 2007-09-11 2009-11-18 Gilead Sciences Inc Proceso e intermediarios para la preparacion de inhibidores de integrasa
JP2011526887A (ja) 2008-07-01 2011-10-20 タイゲン バイオテクノロジー カンパニー,リミテッド 抗生物質耐性菌感染症の治療
AU2013296289B2 (en) 2012-08-03 2017-10-05 Gilead Sciences, Inc. Process and intermediates for preparing integrase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9508514A (pt) * 1994-08-02 1997-12-23 Procter & Gamble Processo para fabricação de compostos antimicrobiais
NZ290722A (en) * 1994-08-02 1999-03-29 Procter & Gamble A process for making derivatives of quinolonyl lactam (qla's); intermediates

Also Published As

Publication number Publication date
NZ525569A (en) 2004-09-24
CA2427831C (en) 2009-08-18
KR100603163B1 (ko) 2006-07-24
DE60112325T2 (de) 2006-05-24
WO2002048113A1 (en) 2002-06-20
CZ20031379A3 (cs) 2003-11-12
EP1343766B1 (en) 2005-07-27
ES2247190T3 (es) 2006-03-01
HUP0303991A3 (en) 2012-09-28
BR0116229A (pt) 2003-11-04
AU2002229057B2 (en) 2005-04-21
JP2010001315A (ja) 2010-01-07
PL207394B1 (pl) 2010-12-31
KR20030063420A (ko) 2003-07-28
IL155677A (en) 2009-02-11
IL155677A0 (en) 2003-11-23
NO20032667D0 (no) 2003-06-12
NO325236B1 (no) 2008-03-03
HUP0303991A2 (hu) 2004-04-28
JP2004515542A (ja) 2004-05-27
CN1232508C (zh) 2005-12-21
EP1343766A1 (en) 2003-09-17
AU2905702A (en) 2002-06-24
DK1343766T3 (da) 2005-10-31
JP4417007B2 (ja) 2010-02-17
CA2427831A1 (en) 2002-06-20
NO20032667L (no) 2003-08-14
PL363355A1 (en) 2004-11-15
DE60112325D1 (de) 2005-09-01
CN1481365A (zh) 2004-03-10
ATE300522T1 (de) 2005-08-15

Similar Documents

Publication Publication Date Title
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
NZ536141A (en) Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
RS86804A (en) Quinoline and isoquinoline derivatives method for the production thereof and use therof as anti-inflammatory agents
RS59404A (en) Method for producing scopine esters
AU2905702A (en) Cyclization process step in the making of quinolones and naphthyridines
MXPA04001647A (es) Proceso para la preparacion de un derivado de 14-hidroxinormorfinona.
IL154014A0 (en) Process for the preparation of 2-aminoethylpyridines
MXPA04000382A (es) Proceso para preparacion de l-ribavirina.
HK1059778A1 (en) A process for the preparation of taxan derivatives
MXPA04004937A (es) Proceso para preparar 3,3??,3,6??,-tetraalquil-2,2??-bifenoles y 3,??,6,??-tetraalquil-5,??-dihalo-2,??-bifenoles.
MXPA02001406A (es) Heterociclilos-2h-cromenos substituidos.
AU2002233708A1 (en) Process for producing quinoline-3-carboxylic acid compound
GB0103240D0 (en) Organic compounds
TR200001819T2 (tr) COPD tedavi yöntemi.
HK1080475A1 (en) A process for the preparation of the 14-beta-hydroxy-baccatin III-1, 14-carbonate
PL353926A1 (en) Process for the preparation of 2-cyanopyridines
TR200200995T2 (tr) 7-amino-3-metksimetil-3-sefem-4-karbosilik asitin hazırlanmasına yönelik proses.
IL161443A0 (en) A process for the preparation of the 14beta-hydroxy-baccatin iii-1,14-carbonate
SE0000382D0 (sv) New process
WO2003044877A3 (en) Light emitting device and compounds for use therein
AP2001002195A0 (en) Novel process for the preparation of pyrazolopyrimidinones.
AU2001232347A1 (en) Process for producing cyclic compound
DE50203367D1 (de) Verfahren zur herstellung von orthocarbonsäuretrialkylestern
WO2004103961A3 (en) Sulfated bis-cyclic agents
UA42307A (uk) 4-диметиламіно-3-формілбензойна кислота та спосіб її одержання

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights
GB Transfer or rights